SAB Biotherapeutics, Inc. Common Stock (SABS)

Health Care·equity

$2.98

+3.11% today

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

25/ 100

Score level

Below average

6 of 6 checks had data

Price trend score is near the bottom of its range — score for how it compares with the broader market is near the bottom of its range.

SABS scores higher than 21% of the 1,101 tickers we compare it with (Health Care).

As of 10 October 2026, SAB Biotherapeutics, Inc. Common Stock (SABS) scores 25 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.

Updated 10 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 1.13× 30-day average
52-week range: 2.10 – 5.15
Market cap: $319.36M
Earnings date: 11 Nov 2026

Volume: 659,612
Avg. volume (30d): 584,121

Open: 2.90
Previous close: 2.89
Day's range (regular session): 2.81 – 3.02

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: —
P/E (TTM): —
EPS (TTM): —

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for SABS

1 SEC Form 4 insider transaction in the last 90 daysPremium

Counts of rows Market Census holds for SABS. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about SABS right now

SAB Biotherapeutics, Inc. Common Stock (SABS) currently scores 25/100 on the Market Census six-factor composite, at the Below average score level. SABS is +3.11% on the day and +0.00% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of SABS's data reads poorly than well. The level is a "look before you act" flag. It is not advice. SABS's strongest factor is insider trades at 50/100 — a fairly good read on insider buying and selling. Insider filings do not lean toward buying or selling right now — a plain read of public filings, not a signal to follow. The weakest factor is price trend at 5/100 — a well below average technical read. If the rest of the picture is good, a soft price trend often reflects a re-test of support rather than structural breakdown — descriptively, not as a call to act.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See SABS in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score